Remi Gaston-Dreyfus - Mar 31, 2022 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Stock symbol
BNKL
Transactions as of
Mar 31, 2022
Transactions value $
$739,927
Form type
4
Date filed
6/21/2022, 05:47 PM
Previous filing
Dec 13, 2021
Next filing
Jun 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Conversion of derivative security $740K +77.9K +5.06% $9.50* 1.62M Mar 31, 2022 Shares held through GD Holdings and Lombard International Assurance SA F1
holding BNKL Common Stock, par value $0.001 per share 61.3K Mar 31, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective as of March 31, 2022, an aggregate amount of $739,926 of principal and accrued interest in a convertible promissory note issued to GD Holdings converted in accordance with its terms into 77,887 shares of the Issuer's common stock.